Viewing StudyNCT06187961



Ignite Creation Date: 2024-05-06 @ 7:55 PM
Last Modification Date: 2024-10-26 @ 3:17 PM
Study NCT ID: NCT06187961
Status: RECRUITING
Last Update Posted: 2024-01-03
First Post: 2023-12-08

Brief Title: Combined HAIC Lenvatinib and Cadonilimab As Conversion Therapy for Unresectable Hepatocellular Carcinoma
Sponsor: Tongji Hospital
Organization: Tongji Hospital

Conditions & Keywords Data

Conditions:
Name
Hepatocellular Carcinoma Non-resectable
Keywords:
Name View
Hepatic Arterial Infusion Chemotherapy View
Cadonilimab View
Lenvatinib View
Downstaging conversion therapy View
Hepatocellular Carcinoma View